Clinical Trials Browser

Phase 2 × Oropharyngeal Neoplasms × Gabapentin × Clear all

NCT03423264 2024-07-31

PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing

Phase 2 Withdrawn

Oropharyngeal Neoplasms